CTX-M-15 extended-spectrum β-lactamase from Nigerian Klebsiella pneumoniae
Open Access
- 30 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (1) , 24-30
- https://doi.org/10.1093/jac/dki429
Abstract
Objectives: In this study, extended-spectrum β-lactamases (ESBLs) were characterized from 30 selected multidrug-resistant Klebsiella pneumoniae strains isolated from patients with community-acquired urinary tract infections from Southwest Nigeria. Methods: The β-lactamases were phenotypically characterized using isoelectric focusing, genotypically characterized using PCR assays and hybridization of the PCR products. Two of the blaCTX-M genes were completely sequenced. The location of the CTX-M-type genes was determined using transformation, DNA–DNA hybridization, PCR assays and hybridization of the PCR products from the Escherichia coli transformants. Results: All 30 isolates produced at least one β-lactamase. Seventeen of the isolates were resistant to cefotaxime, and had ≥100-fold reduction in susceptibility with cefotaxime plus clavulanic acid (4 mg/L), indicating the presence of an ESBL. The 17 isolates were shown to have blaCTX-M genes that were associated with large plasmids (≥58 kb), which also carried a tetracycline resistance gene, tet(A), and various aminoglycoside resistance genes. Two CTX-M-type genes were sequenced and had amino acid sequences indistinguishable from previously sequenced CTX-M-15 β-lactamases. The ISEcp1 element was located upstream of blaCTX-M-15 in the same position as previously described. In addition, 23 of the isolates produced TEM β-lactamases, 27 produced SHV β-lactamases and four produced AmpC β-lactamases. Conclusions: Thirty K. pneumoniae produced multiple β-lactamases, with 57% producing CTX-M enzymes. This is the first characterization of CTX-M-15-positive K. pneumoniae in Western Africa.Keywords
This publication has 19 references indexed in Scilit:
- High Rate of Fatal Cases of Pediatric Septicemia Caused by Gram-Negative Bacteria with Extended-Spectrum Beta-Lactamases in Dar es Salaam, TanzaniaJournal of Clinical Microbiology, 2005
- Emergence of CTX-M-15-Producing Enterobacteria in Cameroon and Characterization of a bla CTX-M-15 -Carrying ElementAntimicrobial Agents and Chemotherapy, 2005
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- CTX-M-12 β-Lactamase in a Klebsiella pneumoniae Clinical Isolate in ColombiaAntimicrobial Agents and Chemotherapy, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Multiple CTX-M-Type Extended-Spectrum β-Lactamases in Nosocomial Isolates of Enterobacteriaceae from a Hospital in Northern ItalyJournal of Clinical Microbiology, 2003
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Molecular Characterization of a Novel Plasmid-Encoded Cefotaximase (CTX-M-12) Found in Clinical Klebsiella pneumoniae Isolates from KenyaAntimicrobial Agents and Chemotherapy, 2001
- Effective cooling allows sonication to be used for liberation of β-lactamases from Gramnegative bacteriaJournal of Antimicrobial Chemotherapy, 1989
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982